Evidence map›Paper›PMID 36878715›Full record

ArticleThe British journal of ophthalmology2024

Application of artificial intelligence system for screening multiple fundus diseases in Chinese primary healthcare settings: a real-world, multicentre and cross-sectional study of 4795 cases.

Chufeng Gu, Yujie Wang, Yan Jiang, Feiping Xu, Shasha Wang, Rui Liu, Wen Yuan, Nurbiyimu Abudureyimu, Ying Wang, Yulan Lu and 11 more

Registry-linked trialOpen access · hybridAbstract readMulticenter Study
In one paragraph

Article in The British journal of ophthalmology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04592068 (Deep Learning-Based Automated Classification of Multi-Retinal Disease From Fundus Photography), which is not on this map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04592068 unknown statusnot on this map

Deep Learning-Based Automated Classification of Multi-Retinal Disease From Fundus Photography

TypeobservationalSponsorBeijing Tongren HospitalRan2020 to 2021Enrolled10,000ConditionsDeep Learning, Retinal DiseasesArmsRetinal multi-diseases diagnosed by DL algorithm, Retinal multi-diseases diagnosed by expert panel
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Artificial intelligence in preventive care in primary health care settings: a scoping review.Archives of medical sciences. Atherosclerotic diseases · 2026
    Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 5 institutions in 3 countries.

Chufeng GuDepartment of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine; National Clinical Research Center for Eye Diseases; Key Laboratory of Ocular Fundus Diseases; Engineering Center for Visual Science and Photomedicine; Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai, China.
Yujie WangDepartment of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine; National Clinical Research Center for Eye Diseases; Key Laboratory of Ocular Fundus Diseases; Engineering Center for Visual Science and Photomedicine; Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai, China.
Yan JiangDepartment of Ophthalmology, Shibei Hospital of Jing'an District, Shanghai, China.
Feiping XuDepartment of Ophthalmology, Shibei Hospital of Jing'an District, Shanghai, China.
Shasha WangDepartment of Ophthalmology, Shibei Hospital of Jing'an District, Shanghai, China.
Rui LiuDepartment of Ophthalmology, Shibei Hospital of Jing'an District, Shanghai, China.
Wen YuanDepartment of Ophthalmology, Shibei Hospital of Jing'an District, Shanghai, China.
Nurbiyimu AbudureyimuDepartment of Ophthalmology, Bachu County Traditional Chinese Medicine Hospital of Kashgar, Xinjiang, China.
Ying WangDepartment of Ophthalmology, Bachu Country People's Hospital of Kashgar, Xinjiang, China.
Yulan LuDepartment of Ophthalmology, Linfen Community Health Service Center of Jing'an District, Shanghai, China.
Xiaolong LiDepartment of Ophthalmology, Pengpu New Village Community Health Service Center of Jing'an District, Shanghai, China.
Tao WuDepartment of Ophthalmology, Pengpu Town Community Health Service Center of Jing'an District, Shanghai, China.
Li DongBeijing Tongren Eye Center, Key Laboratory of Intraocular Tumor Diagnosis and Treatment, Ophthalmology & Visual Sciences Key Lab, Medical Artificial Intelligence Research and Verification Key Laboratory of the Ministry of Industry and Information Technology, Capital Medical University, Beijing, China.
Yuzhong ChenBeijing Airdoc Technology Co., Ltd, Beijing, China.
Bin WangBeijing Airdoc Technology Co., Ltd, Beijing, China.
Yuncheng ZhangBeijing Airdoc Technology Co., Ltd, Beijing, China.
Wen Bin WeiBeijing Tongren Eye Center, Key Laboratory of Intraocular Tumor Diagnosis and Treatment, Ophthalmology & Visual Sciences Key Lab, Medical Artificial Intelligence Research and Verification Key Laboratory of the Ministry of Industry and Information Technology, Capital Medical University, Beijing, China.
Qinghua QiuDepartment of Ophthalmology, Tong Ren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China corneachen@163.com liud11@163.com zzheng88@sjtu.edu.cn qiuqh9@shsmu.edu.cn.
Zhi ZhengDepartment of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine; National Clinical Research Center for Eye Diseases; Key Laboratory of Ocular Fundus Diseases; Engineering Center for Visual Science and Photomedicine; Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai, China corneachen@163.com liud11@163.com zzheng88@sjtu.edu.cn qiuqh9@shsmu.edu.cn.ORCID 0000-0001-8435-0240
Deng LiuBachu Country People's Hospital of Kashgar, Xinjiang, China corneachen@163.com liud11@163.com zzheng88@sjtu.edu.cn qiuqh9@shsmu.edu.cn.
Jili ChenDepartment of Ophthalmology, Shibei Hospital of Jing'an District, Shanghai, China corneachen@163.com liud11@163.com zzheng88@sjtu.edu.cn qiuqh9@shsmu.edu.cn.ORCID 0000-0002-4080-0534
Shanghai Zhabei District Shibei Hospital · CNShanghai Jiao Tong University · CNCapital Medical University · CNShanghai Eye Disease Prevention & Treatment Center · CNShanghai Sunshine Rehabilitation Center · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimsThis study evaluates the performance of the Airdoc retinal artificial intelligence system (ARAS) for detecting multiple fundus diseases in real-world scenarios in primary healthcare settings and investigates the fundus disease spectrum based on ARAS.

methodsThis real-world, multicentre, cross-sectional study was conducted in Shanghai and Xinjiang, China. Six primary healthcare settings were included in this study. Colour fundus photographs were taken and graded by ARAS and retinal specialists. The performance of ARAS is described by its accuracy, sensitivity, specificity and positive and negative predictive values. The spectrum of fundus diseases in primary healthcare settings has also been investigated.

resultsA total of 4795 participants were included. The median age was 57.0 (IQR 39.0-66.0) years, and 3175 (66.2%) participants were female. The accuracy, specificity and negative predictive value of ARAS for detecting normal fundus and 14 retinal abnormalities were high, whereas the sensitivity and positive predictive value varied in detecting different abnormalities. The proportion of retinal drusen, pathological myopia and glaucomatous optic neuropathy was significantly higher in Shanghai than in Xinjiang. Moreover, the percentages of referable diabetic retinopathy, retinal vein occlusion and macular oedema in middle-aged and elderly people in Xinjiang were significantly higher than in Shanghai.

conclusionThis study demonstrated the dependability of ARAS for detecting multiple retinal diseases in primary healthcare settings. Implementing the AI-assisted fundus disease screening system in primary healthcare settings might be beneficial in reducing regional disparities in medical resources. However, the ARAS algorithm must be improved to achieve better performance. TRIAL REGISTRATION NUMBER: NCT04592068.

Indexed as

Diabetic RetinopathyRetinal DrusenAgedArtificial IntelligenceChinaCross-Sectional StudiesFemaleHumansMaleMass ScreeningMiddle AgedPrimary Health CareSensitivity and SpecificityDiagnostic tests/InvestigationPublic healthRetina

Identifiers

PMID36878715
PMCPMC10894824
OpenAlexW4323348175

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.